Visx PRK laser
This article was originally published in The Gray Sheet
Executive Summary
Company submits two-year follow-up data to FDA for its Twenty/Twenty excimer laser for the treatment of myopia via photorefractive keratectomy. The firm submitted a premarket approval application for the device in June 1993. In addition, the firm says that FDA has asked the company for more information on its pending application for use of the Twenty/Twenty in phototherapeutic keratectomy. In response to a panel request, Visx submitted one-year follow up data on PTK patients in May